Quarterly report pursuant to Section 13 or 15(d)

Goodwill and In-process R&D (Details)

v3.21.2
Goodwill and In-process R&D (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2017
Goodwill and In-Process R&D      
Goodwill and intangible asset impairment $ 0.0 $ 0.0  
Pelican Therapeutics, Inc.      
Goodwill and In-Process R&D      
Goodwill acquired     $ 2.2
Pelican Therapeutics, Inc. | In-process R&D      
Goodwill and In-Process R&D      
Finite-lived intangible assets acquired     $ 5.9